Predictors of Non-Alcoholic Fatty Liver Disease in Egyptian Obese Adolescents

Nonalcoholic fatty liver disease (NAFLD) has
increased in conjunction with obesity. The accuracy of risk factors
for detecting NAFLD in obese adolescents has not undergone a
formal evaluation. The aim of this study was to evaluate predictors of
NAFLD among Egyptian female obese adolescents. The study
included 162 obese female adolescents. All were subjected to
anthropometry, biochemical analysis and abdominal ultrasongraphic
assessment. Metabolic syndrome (MS) was diagnosed according to
the IDF criteria. Significant association between presence of MS and
NAFLD was observed. Obese adolescents with NAFLD had
significantly higher levels of ALT, triglycerides, fasting glucose,
insulin, blood pressure and HOMA-IR, whereas decreased HDL-C
levels as compared with obese cases without NAFLD. Receiver–
operating characteristic (ROC) curve analysis shows that ALT is a
sensitive predictor for NAFLD, confirming that ALT can be used as a
marker of NAFLD.

• Moushira Zaki
• Wafaa Ezzat
• Yasser Elhosary
• Omnia Saleh

• Adolescents
• Egyptians
• obesity.

[1] Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A: What are
the risk factors and settings for non-alcoholic fatty liver disease in Asia-
Pacific? J Gastroenterol Hepatol 2007, 22(6):794–800.
[2] Caballeria L, Auladell MA, Toran P, Miranda D, Aznar J, Pera G, Gil D,
Munoz L, Planas J, Canut S, et al: Prevalence and factors associated
with the presence of non alcoholic fatty liver disease in an apparently
healthy adult population in primary care units. BMC Gastroenterol 2007,
7:41.
[3] Bellentani S, Scaglioni F, Marino M, Bedogni G: Epidemiology of
nonalcoholic fatty liver disease. Dig Dis 2010, 28(1):155–161.
[4] Guturu P, Duchini A: Etiopathogenesis of Nonalcoholic Steatohepatitis:
Role of Obesity. Insulin Resistance and Mechanisms of Hepatotoxicity.
IntJ Hepatol 2012, 2012:212865.
[5] Gan L, Chitturi S, Farrell GC: Mechanisms and implications of agerelatedchanges
in the liver: nonalcoholic Fatty liver disease in the
elderly. Curr Gerontol Geriatr Res 2011, 2011:831536.
[6] Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T:
Aging is a risk factor of nonalcoholic fatty liver disease in
premenopausal women. World J Gastroenterol 2012, 18(3):237–243.
[7] Hernaez R: Genetic factors associated with the presence and progression
of nonalcoholic fatty liver disease: a narrative review. Gastroenterol
Hepatol 2012, 35(1):32–41.
[8] Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine
JE. Obesity, insulin resistance, and other clinicopathological correlates
of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143:500–
505
[9] Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese
children. Ultrasonography and liver enzyme levels at diagnosis and
during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428–
1432
[10] Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum
aminotransferase values in overweight and obese adolescents. J Pediatr
2000; 136:727–733.
[11] Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S,
et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J
Gastroenterol Hepatol. 2004;19:854-8.
[12] Must A, Strauss RS. Risks and consequences of childhood and
adolescent obesity. Int J Obes Relat Metab Disord 1999; 23(2):S2–11.
[13] Freedman DS. Clustering of coronary heart disease risk factors among
obese children. J Pediatr Endocrinol Metab 2002; 15:1099108.
[14] Csa´bi G,Torok K, Jeges S, et al. Presence of metabolic cardiovascular
syndrome in obese children. Eur J Pediatr 2000; 159: 91438.
[15] Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum
aminotransferase values in overweight and obese adolescents. J
Pediatr2000;136:711.
[16] Schwimmer JB, McGreal N, Deutsch R, et al. Influence of gender, race
and ethnicity on suspected fatty liver in obese adolescents. Pediatrics
2005;115:e561–5.
[17] Kawasaki T, Hashimoto N, Kikuchi T, et al. The relationship
betweenfatty liver and hyperinsulinemia in obese Japanese children. J
PediatrGastroenterol Nutr 1997;24:317.
[18] Chu CH, Lee JK, Keng HM, Chuang MJ, Lu CC , Wang MC, et al.
Hyperthyroidism Is Associated with Higher Plasma Endothelin-1
Concentrations. Exp Biol Med 2006; 231:1040-1043
[19] Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Teacher DF, Turner
RC . Homeostasis model assessment: insulin resistance and beta cell
functionfrom fasting plasma glucose and insulin concentration in man.
Diabetologia 1985;28:412-419.
[20] Zimmet P, Alberti G, Kaufman F et al., et al., “The metabolic syndrome
in children and adolescents,” The Lancet, vol. 369, no. 9579, pp. 2059–
2061, 2007
[21] Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani
S: Prevalence of and risk factors for nonalcoholic fatty liver disease: the
Dionysos nutrition and liver study. Hepatology 2005, 42(1):44–52.
[22] Angulo P: Obesity and nonalcoholic fatty liver disease. Nutr Rev 2007,
65(6 Pt 2):S57–S63.
[23] Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini, et
al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Hepatology. 2003;37:917-23.
[24] Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, et
al. Nonalcoholicfatty liver syndrome: a hepatic consequence of common
metabolic diseases. J Gastroenterol Hepatol. 2003;18:588-94.
[25] Boza C, Riquelme A, Ibaeٌz L, Duarte I, Norero E, Viviani P, et al.
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients
undergoing gastricbypass. Obes Surg. 2005;15:1148-53.
[26] Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease:
predictors of nonalcoholic steatohepatitis and liver fibrosis in the
severely obese. Gastroenterology. 2001;121:91-100.
[27] Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al.
Liver pathology and the metabolic syndrome X in severe obesity. J Clin
Endocrinol Metab. 1999;84:1513-7.
[28] Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis:
associationwith obesity and insulin resistance, and influence of weight
loss. Diabetes Metab. 2000; 26:98-106.
[29] Fan JG, Farrell GC: Epidemiology of non-alcoholic fatty liver disease in
China. J Hepatol 2009, 50(1):204–210.
[30] Angulo P: GI epidemiology: nonalcoholic fatty liver disease.
AlimentPharmacol Ther 2007, 25(8):883–889
[31] Lee K, Sung JA, Kim JS, Park TJ: The roles of obesity and gender on
the relationship between metabolic risk factors and non-alcoholic fatty
liverdisease in Koreans. Diabetes Metab Res Rev 2009, 25(2):150–155.
[32] Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani
S: Prevalence of and risk factors for nonalcoholic fatty liver disease:
theDionysos nutrition and liver study. Hepatology 2005, 42(1):44–52.
[33] Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, Meher C,
Rao M: Prevalence of nonalcoholic fatty liver disease in coastal eastern
India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004,
25(2):76–79.
[34] Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA,
Boerwinkle E, Cohen JC, Hobbs HH: Genetic variation in PNPLA3
confers susceptibility to nonalcoholic fatty liver disease. Nat Genet
2008, 40(12):1461–1465.
[35] Daly AK, Ballestri S, Carulli L, Loria P, Day CP: Genetic determinants
of susceptibility and severity in nonalcoholic fatty liver disease. Expert
Rev Gastroenterol Hepatol 2011, 5(2):253–263.